Retina Vitreous Center

Edmond, Oklahoma 73103

2 studies enrolling now · 20 studies all time

What they study most

Age Related Macular Degeneration (ARMD), Age-Related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Epiretinal Membrane, Full-thickness Macular Holes (MH), Geographic Atrophy, Geographic Atrophy of the Macula, Macular Degeneration, Macular Neovascularization Secondary to Age-Related Macular Degeneration, Multiple Sclerosis, Neovascular Age-Related Macular Degeneration

Studies at this site

• Extension Study for the Port Delivery System With Ranibizumab (Portal) — Recruiting now
• Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR — Recruiting now
• Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM — Recruiting now
• Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — Running, not enrolling
• An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration — Running, not enrolling
• 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Running, not enrolling
• ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) — Running, not enrolling
• A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — Running, not enrolling
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema — Completed
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) — Completed
• The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) — Completed
• A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration — Completed
• Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
• Effects of Pneumatic Vitreolysis on Macular Hole — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS) — Stopped early